PVLA Palvella Therapeutics, Inc.
$132.91▲ +5.29%
Healthcare
Other
After hours
$134.00▲ +0.82%
Oct 27, 4:26 PM ET
Volume 178.8K
Avg Volume (10D) 218.1K
Key Metrics & Fundamentals
Market Cap
$1.92B
P/E Ratio
–
Div Yield
0.00%
52W Range
68.96 - 161.38
% vs 50 MA
-6.02%
% vs 200 MA
5.27%
RSI-14
50.2
MACD Histogram
+0.9200
Beta (1Y vs SPY)
1.68
Free Cash Flow
-$12.85M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$19.45M
COGS
–
Operating Exp
$21.41M
Operating Income
-$21.41M
EBIT
-$21.41M
Pretax Income
-$21.87M
Net Income
-$21.87M
EPS (Diluted)
-1.52
Price & Volume History
Loading chart…
Recent News
Palvella Therapeutics Eyes QTORIN Launch as Rare-Disease Pipeline Expands
MarketBeat · Oct 25, 2026 2:03 AM ET
What Does Palvella Therapeutics (PVLA) NDA Progress Mean After Its Phase 3 Data?
Simply Wall St. · Oct 24, 2026 5:08 PM ET
Ligand to Host Investor Day on December 8, 2026
GlobeNewswire · Oct 22, 2026 4:01 PM ET
William Blair Expands Biotech Research as Veteran Analyst Alethia Young Initiates Coverage
Business Wire · Oct 21, 2026 12:30 PM ET
William Blair Initiates Coverage on Palvella Therapeutics With Outperform Rating
MT Newswires · Oct 16, 2026 7:46 AM ET
Palvella Therapeutics to Present Phase 3 SELVA and Phase 2 TOIVA Results, Along With New Pediatric Analyses, at 2026 PeDRA Annual Conference
GlobeNewswire · Oct 15, 2026 7:30 AM ET
Palvella Therapeutics Insider Sold Shares Worth $3,579,476, According to a Recent SEC Filing
MT Newswires · Oct 15, 2026 4:00 AM ET
Palvella Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference
GlobeNewswire · Oct 13, 2026 7:30 AM ET
Palvella Therapeutics Announces Three Poster Presentations Highlighting New Data in Microcystic Lymphatic Malformations and DSAP at Fall Clinical Dermatology 2026
GlobeNewswire · Oct 12, 2026 7:30 AM ET
Palvella Therapeutics Wins Additional US FDA Grant Funding for Rare Skin Disease Drug
MT Newswires · Sep 28, 2026 8:17 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See PVLA's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.